Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,548.00
(
1.89%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,662.06
(
0.25%
)
News Focus
News Focus
Post# of 257443
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Biopharm investor

Send PM Follow Ignore
Followers 6
Posts 166
Boards Moderated 0
Alias Born 06/25/2004

Biopharm investor

Re: drbio45 post# 25498

Sunday, 03/12/2006 10:21:03 PM

Sunday, March 12, 2006 10:21:03 PM

Post# of 257443
drbio45, re: Priority Review

"Does anyone know of cases when a company had fast track and didn't get priority review?"

Genta's lead drug, Genasense, has Fast Track status and its CLL application did not get Priority Review.

[edit: sorry, I just saw that io_io already answered this]
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today